138 related articles for article (PubMed ID: 20300587)
1. Successful treatment of Cisplatin overdose with plasma exchange.
Yamada Y; Ikuta Y; Nosaka K; Miyanari N; Hayashi N; Mitsuya H; Baba H
Case Rep Med; 2010; 2010():802312. PubMed ID: 20300587
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of cisplatin overdose with plasma exchange.
Choi JH; Oh JC; Kim KH; Chong SY; Kang MS; Oh DY
Yonsei Med J; 2002 Feb; 43(1):128-32. PubMed ID: 11854944
[TBL] [Abstract][Full Text] [Related]
3. A case of massive cisplatin overdose managed by plasmapheresis.
Jung HK; Lee J; Lee SN
Korean J Intern Med; 1995 Jul; 10(2):150-4. PubMed ID: 7495775
[TBL] [Abstract][Full Text] [Related]
4. Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management.
Chu G; Mantin R; Shen YM; Baskett G; Sussman H
Cancer; 1993 Dec; 72(12):3707-14. PubMed ID: 8252487
[TBL] [Abstract][Full Text] [Related]
5. Radical esophagectomy for a 92-year-old woman with granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma: a case report.
Kitani M; Yamagata Y; Tanabe A; Yagi K; Aikou S; Kiyokawa T; Nishida M; Yamashita H; Mori K; Nomura S; Seto Y
World J Surg Oncol; 2016 Oct; 14(1):264. PubMed ID: 27737660
[TBL] [Abstract][Full Text] [Related]
6. Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
Rowinsky EK; Chaudhry V; Forastiere AA; Sartorius SE; Ettinger DS; Grochow LB; Lubejko BG; Cornblath DR; Donehower RC
J Clin Oncol; 1993 Oct; 11(10):2010-20. PubMed ID: 7692001
[TBL] [Abstract][Full Text] [Related]
7. Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
Hofmann G; Bauernhofer T; Krippl P; Lang-Loidolt D; Horn S; Goessler W; Schippinger W; Ploner F; Stoeger H; Samonigg H
BMC Cancer; 2006 Jan; 6():1. PubMed ID: 16390557
[TBL] [Abstract][Full Text] [Related]
8. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin overdose: toxicities and management.
Tsang RY; Al-Fayea T; Au HJ
Drug Saf; 2009; 32(12):1109-22. PubMed ID: 19916578
[TBL] [Abstract][Full Text] [Related]
10. Effect of in vivo administration of cisplatin on the colony forming ability of murine bone marrow cells.
Kumar R; Sodhi A; Singh SM
Int J Immunopharmacol; 1993 Apr; 15(3):281-6. PubMed ID: 8505139
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cisplatin in an esophageal cancer patient on hemodialysis who was treated with a full-dose cisplatin-fluorouracil regimen: A case report.
Amagai H; Murakami K; Sakata H; Uesato M; Hayano K; Kano M; Fujishiro T; Toyozumi T; Yoshihide S; Yamamoto K; Hayashi H; Matsubara H
J Oncol Pharm Pract; 2019 Oct; 25(7):1767-1775. PubMed ID: 30304984
[TBL] [Abstract][Full Text] [Related]
12. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
Jpn J Clin Oncol; 1995 Oct; 25(5):203-7. PubMed ID: 7474408
[TBL] [Abstract][Full Text] [Related]
13. The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.
Takada M; Fukuoka M; Ariyoshi Y; Furuse K; Niitani H; Ota K; Motomiya M; Hasegawa K; Tominaga K; Kuriyama T
Cancer Chemother Pharmacol; 1992; 31(3):182-6. PubMed ID: 1281446
[TBL] [Abstract][Full Text] [Related]
14. Use of granulocyte colony-stimulating factor in the treatment of pancytopenia secondary to colchicine overdose.
Katz R; Chuang LC; Sutton JD
Ann Pharmacother; 1992 Sep; 26(9):1087-8. PubMed ID: 1384817
[TBL] [Abstract][Full Text] [Related]
15. A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
Katada C; Sugawara M; Hara H; Fujii H; Nakajima TE; Ando T; Kojima T; Watanabe A; Sakamoto Y; Ishikawa H; Hosokawa A; Hamamoto Y; Muto M; Tahara M; Koizumi W
Jpn J Clin Oncol; 2021 Feb; 51(2):199-204. PubMed ID: 33147611
[TBL] [Abstract][Full Text] [Related]
16. Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancer.
Nagao S; Nishikawa T; Hanaoka T; Kurosaki A; Iwasa N; Hasegawa K; Fujiwara K
Jpn J Clin Oncol; 2014 Nov; 44(11):1040-4. PubMed ID: 25183770
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF.
Iwasaki M; Adachi Y; Minamino K; Suzuki Y; Zhang Y; Okigaki M; Nakano K; Koike Y; Wang J; Mukaide H; Taketani S; Mori Y; Takahashi H; Iwasaka T; Ikehara S
J Am Soc Nephrol; 2005 Mar; 16(3):658-66. PubMed ID: 15689404
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens.
Mukai J; Shimizu E; Ogura T
Jpn J Cancer Res; 1992 Jul; 83(7):746-53. PubMed ID: 1381342
[TBL] [Abstract][Full Text] [Related]
19. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
Rabinowitz J; Petros WP; Stuart AR; Peters WP
Blood; 1993 May; 81(9):2452-9. PubMed ID: 7683220
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients.
de Wit R; Kruit WH; Lamers CH; van 't Veer MB; Luyten AA; van Beurden V; Harteveld M; Planting AS; Schmitz PI; Stoter G; Bolhuis RL; Verweij J
Br J Cancer; 1998 Jun; 77(12):2363-6. PubMed ID: 9649159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
